THU-224 - Efficacy and safety of Sofosbuvir Plus Daclatasvir bilayer tablet with or without Ribavirin in patients with chronic hepatitis C genotype 4 Infection

Autor:	Hassany, Mohamed, Ramadan, Sameh, Moustafa, Ehab, Eysa, Basem, Zidan, Ahmed, Hassan, Amany, Abdulaziz, Heba, Afify, Shimaa, Saeed, Mohamed, Shalabi, Hanaa, Gomaa, Asmaa, Allam, Naglaa, Abdelsameea, Eman, Badr, Reda, Sabry, Aliaa, Alkhatib, Alzhraa, Sameh, Heba, Elhelbawy, Mostafa, Radwan, Ahmed, Hassany, Sahar, Attia, Enas, Razek, Mai Abdel, Elamrawy, Fatema, Medhat, Waseem, Hamed, Omar, Safwat, Dalia, Ezzat, Doris, Prince, Khaled, Waked, Imam
Zdroj:	In Journal of Hepatology June 2023 78 Supplement 1:S1212-S1212
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect